ACCURATE-project (nrAsthma Control Cost-Utility RAndomized Trial Evaluation Goals of asthma treatment: how high should we go? PJ Honkoop1, RJB Loijmans2, EH Termeer3, JB Snoeck-Stroband1, WB Van den Hout1, WJ

First Page		Document Content
Date: 2015-04-29 02:59:33 Exhaled nitric oxide Boehringer Ingelheim Respiratory therapy Medicine Asthma		ACCURATE-project (nrAsthma Control Cost-Utility RAndomized Trial Evaluation Goals of asthma treatment: how high should we go? PJ Honkoop1, RJB Loijmans2, EH Termeer3, JB Snoeck-Stroband1, WB Van den Hout1, WJ Add to Reading List Source URL: publicaties.zonmw.nl Download Document from Source Website File Size: 850,63 KB Share Document on Facebook

	Global Discovery to Development Innovation Forum - Speaker Bio Andreas Gollner - Research Group Leader Medicinal Chemistry - Boehringer Ingelheim PhD: University of Vienna (Organic Chemistry) Post Doc at Columbia Univer DocID: 1uA19 - View Document
	Microsoft Word - Boehringer Ingelheim 2010 ltr v2.doc DocID: 1ubPw - View Document
	January 3, 2017 Immediately Keri McGrath Happe; ; +Lauren Zierke; ; +Elanco Animal Health Completes Acquisition of Boehringer Ingelheim DocID: 1tQb1 - View Document
	Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees. T DocID: 1skMX - View Document
	Reasons for CRADA Delays In the Past Ongoing • Sponsors hesitant and not DocID: 1rqkp - View Document